BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6303574)

  • 1. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
    Milas L; Hunter N; Reid BO; Thames HD
    Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.
    Milas L; Hersh EM; Stringfellow DA; Hunter N
    J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
    Milas L; Hunter N; Stephens LC; Peters LJ
    Cancer Res; 1984 Dec; 44(12 Pt 1):5567-9. PubMed ID: 6093999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine.
    Yuhas JM
    Cancer Treat Rep; 1979 Jun; 63(6):971-6. PubMed ID: 223759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thermochemotherapy (combined cyclophosphamide and hyperthermia) given at various temperatures with or without glucose administration on a murine fibrosarcoma.
    Urano M; Kim MS; Kahn J; Kenton LA; Li ML
    Cancer Res; 1985 Sep; 45(9):4162-6. PubMed ID: 4028008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in radioresponse of murine tumors by treatment with indomethacin.
    Furuta Y; Hunter N; Barkley T; Hall E; Milas L
    Cancer Res; 1988 Jun; 48(11):3008-13. PubMed ID: 3365690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of WR-2721 against radiation-induced injury of murine gut, testis, lung, and lung tumor nodules.
    Milas L; Hunter N; Reid BO
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):535-8. PubMed ID: 6286549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type.
    Milas L; Ito H; Hunter N; Jones S; Peters LJ
    Cancer Res; 1986 Feb; 46(2):723-7. PubMed ID: 3940638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of misonidazole chemosensitization effect by mild local hyperthermia.
    Wong KH; Urano M
    Int J Radiat Oncol Biol Phys; 1992; 23(3):593-8. PubMed ID: 1612960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.
    Yuhas JM; Culo F
    Cancer Treat Rep; 1980 Jan; 64(1):57-64. PubMed ID: 6247064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of radiation-induced carcinogenesis in mice by misonidazole and WR-2721.
    Hunter NR; Guttenberger R; Milas L
    Int J Radiat Oncol Biol Phys; 1992; 22(4):795-8. PubMed ID: 1312077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.
    Grigsby P; Maruyama Y
    Br J Radiol; 1981 Nov; 54(647):969-72. PubMed ID: 6272925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome protection by WR-2721 and MPG-single and combination treatments.
    Thomas B; Devi PU
    Strahlenther Onkol; 1987 Dec; 163(12):807-10. PubMed ID: 2827332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin.
    Furuta Y; Hall ER; Sanduja S; Barkley T; Milas L
    Cancer Res; 1988 Jun; 48(11):3002-7. PubMed ID: 3130182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
    Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
    Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modification of spontaneous lung metastasis by local radiation combined with or without immunomodifier].
    Shigematsu N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Sep; 50(9):1139-46. PubMed ID: 2247355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.